Literature DB >> 33398037

Identification of PIM1 substrates reveals a role for NDRG1 phosphorylation in prostate cancer cellular migration and invasion.

Russell J Ledet1,2,3, Sophie E Ruff1,2,3, Yu Wang1,2, Shruti Nayak4, Jeffrey A Schneider1,2,3, Beatrix Ueberheide1,4, Susan K Logan5,6, Michael J Garabedian7,8.   

Abstract

PIM1 is a serine/threonine kinase that promotes and maintains prostate tumorigenesis. While PIM1 protein levels are elevated in prostate cancer relative to local disease, the mechanisms by which PIM1 contributes to oncogenesis have not been fully elucidated. Here, we performed a direct, unbiased chemical genetic screen to identify PIM1 substrates in prostate cancer cells. The PIM1 substrates we identified were involved in a variety of oncogenic processes, and included N-Myc Downstream-Regulated Gene 1 (NDRG1), which has reported roles in suppressing cancer cell invasion and metastasis. NDRG1 is phosphorylated by PIM1 at serine 330 (pS330), and the level of NDRG1 pS330 is associated higher grade prostate tumors. We have shown that PIM1 phosphorylation of NDRG1 at S330 reduced its stability, nuclear localization, and interaction with AR, resulting in enhanced cell migration and invasion.

Entities:  

Year:  2021        PMID: 33398037      PMCID: PMC7782530          DOI: 10.1038/s42003-020-01528-6

Source DB:  PubMed          Journal:  Commun Biol        ISSN: 2399-3642


  68 in total

1.  Pim-1 kinase promotes inactivation of the pro-apoptotic Bad protein by phosphorylating it on the Ser112 gatekeeper site.

Authors:  Teija L T Aho; Jouko Sandholm; Katriina J Peltola; Harri P Mankonen; Michael Lilly; Päivi J Koskinen
Journal:  FEBS Lett       Date:  2004-07-30       Impact factor: 4.124

2.  A Pumilio-induced RNA structure switch in p27-3' UTR controls miR-221 and miR-222 accessibility.

Authors:  Martijn Kedde; Marieke van Kouwenhove; Wilbert Zwart; Joachim A F Oude Vrielink; Ran Elkon; Reuven Agami
Journal:  Nat Cell Biol       Date:  2010-09-05       Impact factor: 28.824

3.  Crystal structures of proto-oncogene kinase Pim1: a target of aberrant somatic hypermutations in diffuse large cell lymphoma.

Authors:  Abhinav Kumar; Valsan Mandiyan; Yoshihisa Suzuki; Chao Zhang; Julie Rice; James Tsai; Dean R Artis; Prabha Ibrahim; Ryan Bremer
Journal:  J Mol Biol       Date:  2005-04-22       Impact factor: 5.469

4.  Delineation of prognostic biomarkers in prostate cancer.

Authors:  S M Dhanasekaran; T R Barrette; D Ghosh; R Shah; S Varambally; K Kurachi; K J Pienta; M A Rubin; A M Chinnaiyan
Journal:  Nature       Date:  2001-08-23       Impact factor: 49.962

5.  Interferon-alpha activates multiple STAT proteins and upregulates proliferation-associated IL-2Ralpha, c-myc, and pim-1 genes in human T cells.

Authors:  S Matikainen; T Sareneva; T Ronni; A Lehtonen; P J Koskinen; I Julkunen
Journal:  Blood       Date:  1999-03-15       Impact factor: 22.113

6.  Meta- and Orthogonal Integration of Influenza "OMICs" Data Defines a Role for UBR4 in Virus Budding.

Authors:  Shashank Tripathi; Marie O Pohl; Yingyao Zhou; Ariel Rodriguez-Frandsen; Guojun Wang; David A Stein; Hong M Moulton; Paul DeJesus; Jianwei Che; Lubbertus C F Mulder; Emilio Yángüez; Dario Andenmatten; Lars Pache; Balaji Manicassamy; Randy A Albrecht; Maria G Gonzalez; Quy Nguyen; Abraham Brass; Stephen Elledge; Michael White; Sagi Shapira; Nir Hacohen; Alexander Karlas; Thomas F Meyer; Michael Shales; Andre Gatorano; Jeffrey R Johnson; Gwen Jang; Tasha Johnson; Erik Verschueren; Doug Sanders; Nevan Krogan; Megan Shaw; Renate König; Silke Stertz; Adolfo García-Sastre; Sumit K Chanda
Journal:  Cell Host Microbe       Date:  2015-12-09       Impact factor: 21.023

7.  Molecular determinants of resistance to antiandrogen therapy.

Authors:  Charlie D Chen; Derek S Welsbie; Chris Tran; Sung Hee Baek; Randy Chen; Robert Vessella; Michael G Rosenfeld; Charles L Sawyers
Journal:  Nat Med       Date:  2003-12-21       Impact factor: 53.440

8.  Differential regulation of androgen receptor by PIM-1 kinases via phosphorylation-dependent recruitment of distinct ubiquitin E3 ligases.

Authors:  Douglas E Linn; Xi Yang; Yingqiu Xie; Alan Alfano; Dhanraj Deshmukh; Xin Wang; Hermela Shimelis; Hegang Chen; Wei Li; Kexin Xu; Mingyuan Chen; Yun Qiu
Journal:  J Biol Chem       Date:  2012-05-14       Impact factor: 5.157

9.  Mammalian neurogenesis requires Treacle-Plk1 for precise control of spindle orientation, mitotic progression, and maintenance of neural progenitor cells.

Authors:  Daisuke Sakai; Jill Dixon; Michael J Dixon; Paul A Trainor
Journal:  PLoS Genet       Date:  2012-03-29       Impact factor: 5.917

10.  Phosphorylation of Notch1 by Pim kinases promotes oncogenic signaling in breast and prostate cancer cells.

Authors:  Niina M Santio; Sebastian K-J Landor; Laura Vahtera; Jani Ylä-Pelto; Elina Paloniemi; Susumu Y Imanishi; Garry Corthals; Markku Varjosalo; Ganesh Babu Manoharan; Asko Uri; Urban Lendahl; Cecilia Sahlgren; Päivi J Koskinen
Journal:  Oncotarget       Date:  2016-07-12
View more
  4 in total

Review 1.  A systematic review on active sites and functions of PIM-1 protein.

Authors:  Youyi Zhao; Aziz Ur Rehman Aziz; Hangyu Zhang; Zhengyao Zhang; Na Li; Bo Liu
Journal:  Hum Cell       Date:  2022-01-09       Impact factor: 4.174

2.  Multifaceted and Intricate Oncogenic Mechanisms of NDRG1 in Head and Neck Cancer Depend on Its C-Terminal 3R-Motif.

Authors:  Guo-Rung You; Joseph T Chang; Hsiao-Fan Li; Ann-Joy Cheng
Journal:  Cells       Date:  2022-05-07       Impact factor: 7.666

3.  Claudin-2 promotes colorectal cancer growth and metastasis by suppressing NDRG1 transcription.

Authors:  Mingtian Wei; Yaguang Zhang; Xuyang Yang; Pingfan Ma; Yan Li; Yangping Wu; Xiangzheng Chen; Xiangbing Deng; Tinghan Yang; Xiaobing Mao; Lei Qiu; Wenjian Meng; Bo Zhang; Ziqiang Wang; Junhong Han
Journal:  Clin Transl Med       Date:  2021-12

4.  PIM1 phosphorylation of the androgen receptor and 14-3-3 ζ regulates gene transcription in prostate cancer.

Authors:  Sophie E Ruff; Nikita Vasilyev; Evgeny Nudler; Susan K Logan; Michael J Garabedian
Journal:  Commun Biol       Date:  2021-10-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.